WO2025149983 - DELIVERY PLATFORM WITH INTEGRATED NON-VIRAL TRANSFECTION AND CELL PROCESSING
National phase entry is expected:
Publication Number
WO/2025/149983
Publication Date
17.07.2025
International Application No.
PCT/IB2025/050324
International Filing Date
10.01.2025
Title **
[English]
DELIVERY PLATFORM WITH INTEGRATED NON-VIRAL TRANSFECTION AND CELL PROCESSING
[French]
PLATEFORME DE DISTRIBUTION AVEC TRANSFECTION NON VIRALE INTÉGRÉE ET TRAITEMENT DE CELLULE
Applicants **
AVECTAS LIMITED
Inventors
THOMMES, Jorg
MAGUIRE, Michael
Priority Data
63/620,298
12.01.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3341 | |
| EPO | Filing, Examination, Granting | 15144 | |
| Japan | Filing, Examination, Granting | 2309 | |
| South Korea | Filing, Examination, Granting | 2385 | |
| USA | Filing, Examination, Granting | 5640 |
Total:
28,819
Contact Us
Abstract[English]
The current subject matter provides a cell engineering platform for vector-free and/or viral delivery of payload/cargo compounds and compositions into cells. The platform achieves delivery to cells quickly and in an easy to use manner. Related apparatus, systems, techniques, articles and compositions are also described.[French]
La présente étude concerne une plate-forme d'ingénierie cellulaire pour la distribution sans vecteur et/ou virale de composés et de compositions de charge utile/charge dans les cellules. La plateforme permet l'administration à des cellules rapidement et d'une manière facile à utiliser. Des appareils, des systèmes, des techniques, des compositions et des articles connexes sont également décrits.